Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.
Felix HeinrichIsabell CordtsRene GüntherBenjamin StolteDaniel ZellerCarsten SchröterUte WeyenMartin RegensburgerJoachim WolfIlka SchneiderAndreas HermannMoritz MetelmannZacharias KohlRalf A LinkerJan Christoph KochFlorentine RadelfahrErik SchönfelderPavel GardtTara Mohajer-PeseschkianAlma OsmanovicThomas KlopstockJohannes DorstAlbert C LudolphOliver SchöffskiMatthias BoentertTim HagenackerMarcus DeschauerPaul LingorSusanne PetriOlivia Schreiber-KatzPublished in: Journal of neurology (2023)
As loss of individual autonomy was the main cost predictor, therapeutic and supportive measures to maintain this autonomy may contribute to reducing high personal burden and also long-term costs, e.g., care dependency and absenteeism from work.